2013
DOI: 10.1007/s40134-013-0036-6
|View full text |Cite
|
Sign up to set email alerts
|

Radiologic Assessment of Lymph Nodes in Oncologic Patients

Abstract: Status of lymph node metastasis has important implications in deciding treatment of oncologic patients. The appropriate choice of imaging modality is crucial to obtain accurate evaluation of lymph node status. Current imaging methods are mainly divided into two categories, conventional structural imaging and more recently emerging functional imaging. In depth understanding of these imaging tools is essential in making the correct choice for individual patients, and eventually for better diagnosis and treatment. Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(30 citation statements)
references
References 70 publications
1
28
0
1
Order By: Relevance
“…To evaluate the treatment response, to avoid continuing chemotherapy if the patient is not responding, or to change the planned treatment if the disease progresses, upper abdomen and chest CT should be used for distance disease assessment during or after neoadjuvant chemotherapy (consensus, LE: 5). MRI or pelvic CT is the most suitable imaging modality for loco-regional response evaluation of neoadjuvant chemotherapy (recommendation, LE: 5), as it can show deep lymph nodes and masses in the pelvis and retroperitoneum (Mao et al 2014 ).…”
Section: Resultsmentioning
confidence: 99%
“…To evaluate the treatment response, to avoid continuing chemotherapy if the patient is not responding, or to change the planned treatment if the disease progresses, upper abdomen and chest CT should be used for distance disease assessment during or after neoadjuvant chemotherapy (consensus, LE: 5). MRI or pelvic CT is the most suitable imaging modality for loco-regional response evaluation of neoadjuvant chemotherapy (recommendation, LE: 5), as it can show deep lymph nodes and masses in the pelvis and retroperitoneum (Mao et al 2014 ).…”
Section: Resultsmentioning
confidence: 99%
“…Lymph nodes were classified preoperatively as suspicious according to the original RECIST 1.1 criteria, the RECIST 1.1 amendment specifically designed for lymph node assessment and further supporting literature [21,22]. Criteria applied to determine malignancy were first and foremost the size with a short-axis diameter > 1.5 cm but also further ancillary imaging features such as spherical shape, no fatty hilus, strong contrast enhancement, MR-diffusion restriction, central necrosis, threshold growth and distribution pattern [23]. Examined lymph node stations were the hepatoduodenal ligament, retropancreatic, the lesser curvature, interaortocaval, and superior to the diaphragm.…”
Section: Preoperative Evaluation and Imagingmentioning
confidence: 99%
“…Finally, there was heterogeneity with respect to the radiation dose delivered over this 10-year period, and it is possible that rates of regional lymph node recurrence are underestimated in this study due to limitations in sensitivity of currently available imaging modalities. 22 The strengths of this study include a comprehensive assessment of patterns of failure and real-world outcomes of cholangiocarcinoma patients treated with SBRT. Our findings compare favorably to previously published series.…”
Section: Discussionmentioning
confidence: 99%